These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16936187)

  • 1. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.
    Antonetti DA; Barber AJ; Bronson SK; Freeman WM; Gardner TW; Jefferson LS; Kester M; Kimball SR; Krady JK; LaNoue KF; Norbury CC; Quinn PG; Sandirasegarane L; Simpson IA;
    Diabetes; 2006 Sep; 55(9):2401-11. PubMed ID: 16936187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic retinopathy].
    Verougstraete C
    Rev Med Brux; 1995; 16(4):253-7. PubMed ID: 7481237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis.
    Gardiner TA; Archer DB; Curtis TM; Stitt AW
    Microcirculation; 2007 Jan; 14(1):25-38. PubMed ID: 17365659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of research on pathogenesis and medical treatment of diabetic retinopathy].
    Geng S; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):76-81. PubMed ID: 18510248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of flickering light on the retinal vessels in diabetic patients.
    Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA
    Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic retinopathy].
    Aliseda Pérez de Madrid D; Berástegui I
    An Sist Sanit Navar; 2008; 31 Suppl 3():23-34. PubMed ID: 19169292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC inhibition and diabetic microvascular complications.
    Clarke M; Dodson PM
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):573-86. PubMed ID: 18054736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
    Kowluru RA; Menon B; Gierhart DL
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of preventing vision loss from diabetic retinopathy.
    Hainsworth DP
    Mo Med; 2005; 102(1):41-5; quiz 45-6. PubMed ID: 15754616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina.
    Kobayashi T; Puro DG
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2350-5. PubMed ID: 17460301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Programme preventing vision loss due to diabetes].
    Bandurska-Stankiewicz E; Wiatr D
    Klin Oczna; 2007; 109(7-9):359-62. PubMed ID: 18260299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension.
    Silva KC; Pinto CC; Biswas SK; de Faria JB; de Faria JM
    Curr Eye Res; 2007 Jun; 32(6):533-41. PubMed ID: 17612969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could diabetic retinopathy be an autoimmune disease?
    Kastelan S; Zjacić-Rotkvić V; Kastelan Z
    Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular manifestations of diabetes: 285 cases].
    Zghal-Mokni I; Nacef L; Letaief I; Mahjoub S; Bouguila H; Blouza S; Jeddi A; Ayed S
    Tunis Med; 2008 Nov; 86(11):1004-7. PubMed ID: 19213494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.
    Wang FH; Liang YB; Zhang F; Wang JJ; Wei WB; Tao QS; Sun LP; Friedman DS; Wang NL; Wong TY
    Ophthalmology; 2009 Mar; 116(3):461-7. PubMed ID: 19168222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.